Guangjun Nie is a Professor at the National Center for Nanoscience and Technology, China. He obtained his Ph.D in Biochemistry and Biophysics at the Institute of Biophysics, CAS in 2002. Currently, he is a National Distinguished Youth Scientist. He was awarded the Hundred Talent Program Scholar of CAS in 2008 and was a Chief Scientist of a MoST National Basic Research Program. He has a long standing interest in cancer biology, blood physiology and pathophysiology of human disorders involving disregulation of redox balance and metal metabolism. Currently, his main interests are design of bio-inspired materials to overcome the current barriers in tumor therapy and nanobiology. In particular, his group is working toward controlling the chemical properties of multi-functional nanoparticles in order to allow specific targeting and regulation of tumor cells and their microenvironment.

His most recent research activities generated a group of interdisciplinary works in nanobiology, nanomedicine and blood physiology fields, including over 100 papers published in Acc Chem Res, Adv Mater, Angew Chem, Adv Funct Mater, Blood, Biomaterials, Br J Haematol, JACS, JBC, Molecular Cancer Therapeutics and Small. He has filled over 32 patents on novel nanomedicines and 16 of them have been granted, with two patents on antitumor drug development have been transferred to a biotechnology firm for pre-clinical investigation. He is an experienced supervisor of postgraduate students and collaborates widely both within China and internationally. Now he is leading a multidisciplinary team with over 30 people working toward better and safer antitumor nanomedicine for pancreatic cancer and liver cancer. He is also the Affiliated Professor of Northeast University, Shenyang, China and East China University of Science and Technology, Shanghai. He is also an Affiliated Senior Member of Houston Methodist Research Institute, Houston, US since 2010.